Evidence map›Paper›PMID 41178152›Full record

ArticleJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG2026

Simulating the impact of an educational and digital approach using patient journey modelling to overcome practical challenges in the management of chronic spontaneous urticaria in Germany.

Ralph von Kiedrowski, Mark Berneburg, Mona Biermann, Hanna Bonnekoh, Michael Fritz, Max Tischler, Martin Metz, Sebastian Volc, Nicola Wagner, Alexander Zink and 1 more

Abstract read
In one paragraph

Article in Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ralph von KiedrowskiCompany for Medical Study & Service Selters GmbH (CMS3), Selters, Germany.
Mark BerneburgDepartment of Dermatology, University Hospital Regensburg, Regensburg, Germany.
Mona BiermannNovartis Pharma GmbH, Nuremberg, Germany.
Hanna BonnekohInstitute of Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Michael FritzNovartis Pharma GmbH, Nuremberg, Germany.
Max TischlerHaut + Laser Practice Dr. Tischler+Team, Dortmund, Germany.ORCID https://orcid.org/0000-0001-7509-9293
Martin MetzInstitute of Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.ORCID https://orcid.org/0000-0002-4070-9976
Sebastian VolcDepartment of Dermatology, University Hospital Tübingen, University of Tübingen, Tübingen, Germany.ORCID https://orcid.org/0000-0003-3543-4848
Nicola WagnerDepartment of Dermatology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Alexander ZinkDepartment of Dermatology and Allergy, Biederstein, School of Medicine, Technical University of Munich, Munich, Germany.ORCID https://orcid.org/0000-0001-9313-6588
Petra NathanNovartis Pharma GmbH, Nuremberg, Germany.ORCID https://orcid.org/0009-0002-6787-0804

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectiveDespite the availability of guidelines and effective escalation therapies, chronic spontaneous urticaria (CSU) is often inadequately treated in Germany. Implementation science can help to transfer evidence-based care into practice. The aim of this work is to analyze practical challenges, develop intervention strategies and simulate their potential impact on patient outcomes. METHODOLOGY: A multi-stage approach with literature research, market research, expert interviews and focus groups with healthcare professionals enabled a comprehensive context analysis. Based on this, intervention strategies were developed and simulated using a patient journey model. The focus was on an educational program and telemedicine monitoring.

resultsCSU management is hampered by delayed diagnosis and underutilization of available therapies. Barriers include lack of knowledge of diagnostic tools, lack of referral standards and structural barriers to the use of patient-reported outcomes. Two strategies were proposed: a training program to improve diagnostics and therapy and telemedicine to optimize monitoring. Simulations show that educational measures could increase diagnosis and treatment rates and digital approaches could reduce waiting times.

conclusionThe study systematically identifies barriers in CSU care and uses a patient journey approach to show the potential effects of targeted implementation strategies. Educational measures in particular could significantly improve care.

Indexed as

Chronic UrticariaPatient Education as TopicGermanyHumansTelemedicineBarrierschronic spontaneous urticariaeducationimplementation scienceinterventionspatient journey modellingsimulationtelemedicine

Identifiers

PMID41178152
PMCPMC12968947

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.